Purespring Therapeutics and SwanBio Therapeutics announce licensing agreement for use of FunSel screening platform – Yahoo Finance

Purespring Therapeutics and SwanBio Therapeutics announce licensing agreement for use of FunSel screening platform

FunSel is Purespring’s proprietary in-vivo ‘gene search engine’, which allows functional selection of therapeutic factors unconstrained by previous drug discovery bias

SwanBio will use FunSel to advance AAV-based gene therapies for use in neurological diseases

London, UK & Philadelphia, USA — 18 July 2022—Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, has entered into a collaborative licensing agreement with SwanBio Therapeutics, a gene therapy company advancing adeno-associated virus (AAV)-based therapies for inherited neurological conditions, for the use of FunSel, Purespring’s proprietary gene therapy search engine.

FunSel enables a completely new way of discovering effective biological drugs, removing the narrow, target-focused bias built into traditional drug discovery. FunSel allows ‘…

Read Full Story: https://finance.yahoo.com/news/purespring-therapeutics-swanbio-therapeutics-announce-110000531.html

The post Purespring Therapeutics and SwanBio Therapeutics announce licensing agreement for use of FunSel screening platform – Yahoo Finance first appeared on SEO, Marketing and Social News | OneSEOCompany.com.

source: https://news.oneseocompany.com/2022/07/18/purespring-therapeutics-and-swanbio-therapeutics-announce-licensing-agreement-for-use-of-funsel-screening-platform-yahoo-finance_2022071823771.html

Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.